tiprankstipranks
Trending News
More News >
Prothena (PRTA)
NASDAQ:PRTA
US Market

Prothena (PRTA) Technical Analysis

Compare
615 Followers

Technical Sentiment

Overall Consensus
Strong Sell
0Bullish
0Neutral
13Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Prothena’s (PRTA) Moving Averages Convergence Divergence (MACD) indicator is -0.55, suggesting Prothena is a Buy.
Prothena’s (PRTA) 20-Day exponential moving average is 12.43, while Prothena’s (PRTA) share price is $10.48, making it a Sell.
Prothena’s (PRTA) 50-Day exponential moving average is 13.45, while Prothena’s (PRTA) share price is $10.48, making it a Sell.

Prothena (PRTA) Pivot Points

Apr 10, 2025, 08:18 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.95
11.36
11.87
12.29
12.80
13.21
13.72
Fibonacci
11.36
11.72
11.93
12.29
12.64
12.86
13.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prothena (PRTA) Moving Averages

Apr 10, 2025, 08:18 AM
Period
Simple
Exponential
MA5
11.13Sell
11.07Sell
MA10
11.93Sell
11.67Sell
MA20
12.61Sell
12.43Sell
MA50
13.84Sell
13.45Sell
MA100
14.15Sell
14.53Sell
MA200
17.13Sell
16.93Sell
Prothena’s (PRTA) 10-Day exponential moving average is 11.67, while Prothena’s (PRTA) share price is $10.48, making it a Sell.
Prothena’s (PRTA) 100-Day exponential moving average is 14.53, while Prothena’s (PRTA) share price is $10.48, making it a Sell.
Prothena’s (PRTA) stock price is $10.48 and Prothena’s (PRTA) 50-day simple moving average is 13.84, creating a Sell signal.
Prothena’s (PRTA) stock price is $10.48 and Prothena’s (PRTA) 100-day simple moving average is 14.15, creating a Sell signal.
Prothena’s (PRTA) stock price is $10.48 and Prothena’s (PRTA) 200-day simple moving average is 17.13, creating a Sell signal.

Prothena (PRTA) Technical Indicators

Apr 10, 2025, 08:18 AM
Name
Value
Implied Action
RSI (14)
34.08
Neutral
STOCH (9,6)
32.77
Neutral
STOCHRSI (14)
22.04
Neutral
MACD (12,26)
-0.55
Buy
ADX (14)
23.92
Neutral
Williams %R
-89.04
Buy
CCI (14)
-149.80
Buy
ATR (14)
0.90
-
Ultimate Oscillator
48.40
Neutral
ROC
-18.63
Sell
Prothena’s (PRTA) Relative Strength Index (RSI) is 34.08, creating a Neutral signal.
Prothena’s (PRTA) Trend Strength Indicator (ADX) is 23.92, creating a Neutral signal.
Prothena’s (PRTA) Commodity Channel Index (CCI) is -149.80, creating a Buy signal.
Prothena’s (PRTA) Price Rate of Change (ROC) is -18.63, creating a Sell signal.

FAQ

Is PRTA a Buy, Hold, or Sell?
Based on PRTA’s technical indicators, PRTA is a Strong Sell.
    What is PRTA’s RSI (14)?
    PRTA’s RSI (14) is 34.08, which suggests PRTA is a Neutral.
      What is PRTA’s MACD?
      PRTA’s MACD is -0.55, which suggests PRTA is a Buy.
        What is PRTA’s 5-day moving average?
        PRTA’s 5-day moving average is 11.13, which suggests PRTA is a Sell.
          What is PRTA’s 20-day moving average?
          PRTA 20-day moving average is 12.61, which suggests PRTA is a Sell.
            What is PRTA’s 50-day moving average?
            PRTA’s 50-day moving average is 13.84, which suggests PRTA is a Sell.
              What is PRTA’s 200-day moving average?
              PRTA’s 200-day moving average is 17.13, which suggests PRTA is a Sell.
                What is PRTA’s Williams % R (14)?
                PRTA’s Williams % R (14) is -89.04, which suggests PRTA is a Buy.
                  What is PRTA’s CCI (14)?
                  PRTA’s CCI (14) is -149.80, which suggests PRTA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis